---
category: news
title: "Dexamethasone identified by AI VIVO as high potential for treatment of COVID-19 ten weeks ago"
excerpt: "AI VIVO, a company combining systems pharmacology and artificial intelligence (AI) to accelerate drug discovery, has announced that its platform corre"
publishedDateTime: 2020-06-18T09:46:00Z
webUrl: "https://www.businesswire.com/news/home/20200618005360/en/Dexamethasone-identified-AI-VIVO-high-potential-treatment"
type: article
quality: 26
heat: 26
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI

images:
  - url: "https://mms.businesswire.com/media/20200618005360/en/799359/23/AI_VIVO_-_LOGO_HIGH_RES.jpg"
    width: 1200
    height: 627
    isCached: true
    title: "Dexamethasone identified by AI VIVO as high potential for treatment of COVID-19 ten weeks ago"

secured: "0iJEhS0tfiEM90ku+pJjGfbne/BI3pMIQvr7/lBldhOK+33yRVf5XxvI5kRvOmdxZaJXUeRdNg5VgyuwVnByeMNlogL+s6OXTfU7FUwf6G9fky59VDAKJrYtmlicVTYjDMfLnEnIHJvVCPoVYg/v66QBH0fm2B38VV02PhI/VNA/q+XwbFMr2XYLqnkUJ69ylNQ85UN14sveppxFi63CnbpVT/jeQ4eBmTh1tG5hHzXMKCS20AQtnq7+kq12FS+Z9++fp8WYzqmPNurdn4Z+VpSDM72Pj9K0DfaSvj/C3fkhCr5pz+ev7dl8dIfwkmmxvyUK8uQg2+a/tP4hcJShWQ==;7vk0GpYZjwwoR/auniZ5aA=="
---

